, Volume 236, Issue 1, pp 281–291 | Cite as

Single stimulation of Y2 receptors in BNSTav facilitates extinction and dampens reinstatement of fear

  • Dilip VermaEmail author
  • Sara Jamil
  • Ramon Osman Tasan
  • Maren Denise Lange
  • Hans-Christian Pape
Original Investigation



Return of fear by re-exposure to an aversive event is a major obstacle in the treatment of fear-related disorders. Recently, we demonstrated that local pharmacological stimulation of neuropeptide Y type 2 receptors (Y2R) in anteroventral bed nucleus of stria terminalis (BNSTav) facilitates fear extinction and attenuates retrieval of remote fear with or without concomitant extinction training. Whether Y2R activation could also protect against re-exposure to traumatic events is still unknown.


Therefore, we investigated reinstatement of remote fear following early Y2R manipulation in BNSTav in relation to concomitant extinction training in mice.


We combined local pharmacological manipulation of Y2Rs in BNSTav with or without extinction training and tested for reinstatement of remote fear 15 days later. Furthermore, we employed immediate early gene mapping to monitor related local brain activation.


Y2R stimulation by local injection of NPY3–36 into BNSTav facilitated extinction, reduced fear reinstatement at remote stages, and mimicked the influence of extinction in groups without prior extinction training. In contrast, Y2R antagonism (JNJ-5207787) delayed extinction and increased reinstatement. Y2R treatment immediately before remote fear tests had no effect. Concomitantly, Y2R activation at early time points reduced the number of c-Fos positive neurons in BNSTav during testing of reinstated remote fear.


Local Y2R stimulation in BNSTav promotes fear extinction and stabilizes suppression of reinstated fear through a long-term influence, even without extinction training. Thus, Y2Rs in BNST are crucial pharmacological targets for extinction-based remote fear suppression.


Neuropeptide Y Y2 receptor Fear extinction Remote fear memory Reinstatement 



We thank S. Kiesling, J. Schröer, M. Becker, P. Berenbrock, and H. Bäumer for excellent technical assistance and animal care. We also thank the Austrian Science Fund (FWF P 25851 to RT).


This work was funded by the Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Münster (PaHC3/001/15, to HCP) and the Sonderforschungsbereich SFB-TRR58 (A03, to HCP).

Compliance with ethical standards

All experiments were carried out in accordance with the European Committees Council Directive (86/609/EEC) and were approved by the local authority LANUV NRW (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen; reference number: 84-02.04.2014.A414).

Conflict of interest

The authors declare that they have no conflict of interests.

Supplementary material

213_2018_5080_MOESM1_ESM.docx (645 kb)
ESM 1 (DOCX 645 kb)


  1. Atwoli L (2015) Epidemiology of posttraumatic stress disorder: prevalence, correlates and consequences. Curr Opin Psychiatry 28:307–311. CrossRefPubMedPubMedCentralGoogle Scholar
  2. Avery SN, Clauss JA, Blackford JU (2016) The human BNST: functional role in anxiety and addiction. Neuropsychopharmacology 41:126–141. CrossRefPubMedGoogle Scholar
  3. Bouton ME (2004) Context and behavioral processes in extinction. Learn Mem 11:485–494. CrossRefPubMedGoogle Scholar
  4. Bouton ME, King DA (1983) Contextual control of the extinction of conditioned fear: tests for the associative value of the context. J Exp Psychol Anim Behav Process 9:248–265CrossRefGoogle Scholar
  5. Bouton ME, Rosengard C, Achenbach GG, Peck CA, Brooks DC (1993) Effects of contextual conditioning and unconditional stimulus presentation on performance in appetitive conditioning. Q J Exp Psychol B 46:63–95Google Scholar
  6. Bouton ME, Westbrook RF, Corcoran KA, Maren S (2006) Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 60:352–360. CrossRefPubMedGoogle Scholar
  7. Brunello N, Davidson JR, Deahl M et al (2001) Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology 43:150–162. CrossRefPubMedGoogle Scholar
  8. Buffalari DM, See RE (2010) Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology 213:19–27. CrossRefPubMedPubMedCentralGoogle Scholar
  9. Daldrup T, Remmes J, Lesting J, Gaburro S, Fendt M, Meuth P, Kloke V, Pape HC, Seidenbecher T (2015) Expression of freezing and fear-potentiated startle during sustained fear in mice. Genes Brain Behav 14:281–291. CrossRefPubMedGoogle Scholar
  10. Dong HW, Petrovich GD, Swanson LW (2001) Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38:192–246CrossRefGoogle Scholar
  11. Dumont Y (2014) Neuropeptide Y pathways in anxiety-related disorders. Biol Psychiatry 76:834–835. CrossRefPubMedGoogle Scholar
  12. Duvarci S, Bauer EP, Pare D (2009) The bed nucleus of the stria terminalis mediates inter-individual variations in anxiety and fear. J Neurosci 29:10357–10361. CrossRefPubMedPubMedCentralGoogle Scholar
  13. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Lüthi A (2009) Amygdala inhibitory circuits and the control of fear memory. Neuron 62:757–771. CrossRefPubMedGoogle Scholar
  14. Flood JF, Morley JE (1989) Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides 10:963–966. CrossRefPubMedGoogle Scholar
  15. Goode TD (2017) Role of the bed nucleus of the stria terminalis in aversive learning and memory. Learn Mem 24:480–491. CrossRefPubMedPubMedCentralGoogle Scholar
  16. Goode TD, Kim JJ, Maren S (2015) Reversible inactivation of the bed nucleus of the stria terminalis prevents reinstatement but not renewal of extinguished fear. eNeuro 2(3).
  17. Haaker J, Gaburro S, Sah A, Gartmann N, Lonsdorf TB, Meier K, Singewald N, Pape HC, Morellini F, Kalisch R (2013) Single dose of L-dopa makes extinction memories context-independent and prevents the return of fear. Proc Natl Acad Sci U S A 110:E2428–E2436. CrossRefPubMedPubMedCentralGoogle Scholar
  18. Hammack SE, Mania I, Rainnie DG (2007) Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98:638–656. CrossRefPubMedGoogle Scholar
  19. Hobin JA, Ji J, Maren S (2005) Ventral hippocampal muscimol disrupts context-specific fear memory retrieval after extinction in rats. Hippocampus 16:174–182. CrossRefGoogle Scholar
  20. Kash TL, Winder DG (2006) Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51:1013–1022. CrossRefPubMedGoogle Scholar
  21. Kim JJ, Jung MW (2005) Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev 30:188–202. CrossRefPubMedPubMedCentralGoogle Scholar
  22. Kornhuber J, Zoicas I (2017) Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice. Sci Rep 7:6821. CrossRefPubMedPubMedCentralGoogle Scholar
  23. LaLumiere RT, Niehoff KE, Kalivas PW (2010) The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration. Learn Mem (Cold Spring Harbor, NY) 17:168–175. CrossRefGoogle Scholar
  24. Larrauri JA, Schmajuk NA (2008) Attentional, associative, and configural mechanisms in extinction. Psychol Rev 115:640–676. CrossRefPubMedGoogle Scholar
  25. Laurent V, Westbrook RF (2009) Inactivation of the infralimbic but not the prelimbic cortex impairs consolidation and retrieval of fear extinction. Learn Mem (Cold Spring Harbor, NY) 16:520–529. CrossRefGoogle Scholar
  26. Lebow MA, Chen A (2016) Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry 21:450–463. CrossRefPubMedPubMedCentralGoogle Scholar
  27. McCall NM, Sprow GM, Delpire E et al (2013) Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice. Front Integr Neurosci 7:100. CrossRefPubMedPubMedCentralGoogle Scholar
  28. Meuth P, Gaburro S, Lesting J, Legler A, Herty M, Budde T, Meuth SG, Seidenbecher T, Lutz B, Pape HC (2013) Standardizing the analysis of conditioned fear in rodents: a multidimensional software approach. Genes Brain Behav 12:583–592. CrossRefPubMedGoogle Scholar
  29. Paxinos G, Franklin KBJ (2008) Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, CambridgeGoogle Scholar
  30. Polack CW, Laborda MA, Miller RR (2013) On the differences in degree of renewal produced by the different renewal designs. Behav Process 99:112–120. CrossRefGoogle Scholar
  31. Quirk GJ (2002) Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery. Learn Mem (Cold Spring Harbor, NY) 9:402–407. CrossRefGoogle Scholar
  32. Quirk GJ, Mueller D (2007) Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33:56–72. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Quirk GJ, Garcia R, González-Lima F (2006) Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 60:337–343. CrossRefPubMedGoogle Scholar
  34. Rasmusson AM, Schnurr PP, Zukowska Z, Scioli E, Forman DE (2010) Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome. Exp Biol Med (Maywood) 235:1150–1162. CrossRefGoogle Scholar
  35. Reichmann F, Hassan AM, Farzi A, Jain P, Schuligoi R, Holzer P (2015) Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice. Sci Rep 5:9970. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Rescorla RA, Heth CD (1975) Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process 1:88–96CrossRefGoogle Scholar
  37. Rescorla RA, Wagner AR (1972) A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Black AH, Prokasy WF (eds) Classical conditioning II: current research and theory. Appleton-Century-Crofts, New York, pp 64–99Google Scholar
  38. Rudy JW, Matus-Amat P (2005) The ventral hippocampus supports a memory representation of context and contextual fear conditioning: implications for a unitary function of the hippocampus. Behav Neurosci 119:154–163. CrossRefPubMedGoogle Scholar
  39. Sah R, Ekhator NN, Jefferson-Wilson L, Horn PS, Geracioti TD Jr (2013) Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology 40:277–283. CrossRefPubMedPubMedCentralGoogle Scholar
  40. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ (2010) Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36:529–538. CrossRefPubMedPubMedCentralGoogle Scholar
  41. Sotres-Bayon F, Sierra-Mercado D, Pardilla-Delgado E, Quirk GJ (2012) Gating of fear in prelimbic cortex by hippocampal and amygdala inputs. Neuron 76:804–812. CrossRefPubMedPubMedCentralGoogle Scholar
  42. Sullivan GM, Apergis J, Bush DEA, Johnson LR, Hou M, Ledoux JE (2004) Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128:7–14. CrossRefPubMedGoogle Scholar
  43. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heilbronn R, Herzog H, Sperk G (2010) The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 30:6282–6290. CrossRefPubMedPubMedCentralGoogle Scholar
  44. Tasan RO, Verma D, Wood J, Lach G, Hörmer B, de Lima TCM, Herzog H, Sperk G (2015) The role of neuropeptide Y in fear conditioning and extinction. Neuropeptides 55:111–126. CrossRefPubMedGoogle Scholar
  45. Verma D, Tasan R, Sperk G, Pape H-C (2018) Neuropeptide Y2 receptors in anteroventral BNST control remote fear memory depending on extinction training. Neurobiol Learn Mem 149:144–153. CrossRefPubMedGoogle Scholar
  46. Waddell J, Morris RW, Bouton ME (2006) Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci 120:324–336. CrossRefPubMedGoogle Scholar
  47. Waddell J, Bouton ME, Falls WA (2008) Central CRF receptor antagonist a-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis. Behav Neurosci 122:1061–1069. CrossRefPubMedGoogle Scholar
  48. Walker DL, Davis M (1997) Double dissociation between the involvement of the bed nucleus of the Stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17:9375–9383. CrossRefPubMedGoogle Scholar
  49. Westbrook RF, Iordanova M, McNally G, Richardson R, Harris JA (2002) Reinstatement of fear to an extinguished conditioned stimulus: two roles for context. J Exp Psychol Anim Behav Process 28:97–110. CrossRefPubMedGoogle Scholar
  50. Wood J, Verma D, Lach G, Bonaventure P, Herzog H, Sperk G, Tasan RO (2015) Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala. Brain Struct Funct 221:3373–3391. CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zimmerman JM, Maren S (2010) The bed nucleus of the stria terminalis is required for the expression of contextual but not auditory freezing in rats with basolateral amygdala lesions. Neurobiol Learn Mem 95:199–205. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute of Physiology 1Westfälische Wilhelms-UniversityMünsterGermany
  2. 2.Department of PharmacologyMedical University InnsbruckInnsbruckAustria

Personalised recommendations